• +1 700 888 1234

  • Effingerstrasse 40 3008 Bern Switzerland

European Society for Medical Oncology ESMO Congress 2023

The ESMO Congress 2023 will take place on-site in Madrid, Spain and online in a virtual format. LuCE will be […]

Call To Action: Survey for 9th LuCE Report

Lung Cancer Europe (LuCE) has launched of an important new survey, together with 39 of its Member Organisations.This survey will […]

Association of Patients with Respiratory Failure and Lung Transplantation joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as the Bulgarian Association of Patients with Respiratory […]

ALK Positive Europe joins LuCE

We are pleased to welcome another new member to Lung Cancer Europe as Alk Positive Europe joins the LuCE family. […]

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer

Some positive news last week when the U.S. Food and Drug Administration (FDA) approved alectinib as an adjuvant treatment for […]

BMS Press Release is out now

Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]